The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...

To understand what drives disease progression in tissues, scientists need more than just a snapshot of cells in ...